{
    "2021-05-04": [
        [
            {
                "time": "2021-04-01",
                "original_text": "Was The Smart Money Right About Eli Lilly and Company (LLY)?",
                "features": {
                    "keywords": [
                        "Smart Money",
                        "Eli Lilly",
                        "LLY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-02",
                "original_text": "Jim Cramer: Don't Bet Against Comebacks in This Second Chance Market",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "Comebacks",
                        "Second Chance Market"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-03",
                "original_text": "Lilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countries",
                "features": {
                    "keywords": [
                        "Lilly",
                        "COVID-19",
                        "donation",
                        "Direct Relief"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-04",
                "original_text": "AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials",
                "features": {
                    "keywords": [
                        "AbCellera",
                        "Lilly",
                        "COVID-19",
                        "Antibody",
                        "Human Trials"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-05",
                "original_text": "Why Lilly's Near-Term Prospects Aren't Looking That Great",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Near-Term Prospects"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "Lilly to donate experimental COVID-19 treatment Olumiant to India",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Olumiant",
                        "India",
                        "donate"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-07",
                "original_text": "Lilly Outlines Robust Plans to Strengthen ESG Commitments Across the Globe",
                "features": {
                    "keywords": [
                        "Lilly",
                        "ESG",
                        "Commitments"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "corporate governance",
                        "environmental"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-08",
                "original_text": "Lilly accelerating baricitinib's availability in India following receipt of permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreements",
                "features": {
                    "keywords": [
                        "Lilly",
                        "baricitinib",
                        "India",
                        "emergency use",
                        "donations",
                        "licensing agreements"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-09",
                "original_text": "New Investor? Buy These 2 Rock-Solid Stalwarts for Safety and Dividends",
                "features": {
                    "keywords": [
                        "Investor",
                        "Rock-Solid Stalwarts",
                        "Safety",
                        "Dividends"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general investment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}